1114. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 840 of 30 June 2026, and the HSE confirmation of 25 August 2026 that no interim system or process will be introduced for Regional Immunisation Committees before the first NIIS report in early 2027, the specific coverage threshold or trigger that would prompt Regional Immunisation Committee intervention in a low-coverage cohor…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Vaccination Programme.
32 questions match, newest first.
791. Deputy Ken O'Flynn asked the Minister for Health the current MenB vaccine uptake rate among the eligible infant cohort in the southwest HSE region compared to the national average; and if she will make a statement on the matter. [48999/26]
839. Deputy Ken O'Flynn asked the Minister for Health if the HSE has set a national target uptake rate for MenB, MenC and MenACWY vaccines under the Primary Childhood and School Immunisation Programmes; if so, the target for each vaccine; the date by which it is to be achieved; and if she will make a statement on the matter. [49257/26]
840. Deputy Ken O'Flynn asked the Minister for Health given that the National Immunisation Information System will only capture data on children born from 1 October 2025 onward, the specific measures in place to improve immunisation data quality and identify coverage gaps for children born before that date; whether any interim system or process will be introduced to support regional immunisation committees in identif…
880. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken or commissioned any cost-effectiveness analysis comparing high-dose influenza vaccines with standard dose influenza vaccines for adults aged 65 years and over for the 2026/2027 influenza season; if so, the date on which that analysis was completed; whether it informed procurement planning for that season; and if she will make …
881. Deputy Ken O'Flynn asked the Minister for Health whether her Department has formally requested the National Immunisation Advisory Committee to review high-dose influenza vaccines since 1 January 2025; if so, the date of that request; whether a written record of the request exists; and whether any further review is currently under consideration. [16703/26]
1007. Deputy Ken O'Flynn asked the Minister for Health if the current tender process for season 2026/2027 will not be delayed by her or cancelled; the reason she would not consider the creation of a “Pathfinder” programme, as developed for the temporary usage of monoclonal antibody in RSV for the past two seasons (details supplied). [14554/26]
1197. Deputy Ken O'Flynn asked the Minister for Health the reason high dose vaccines have been omitted from the recommendations by NIAC as a viable alternative to standard dose vaccines for inclusion in the influenza season 2026/27, especially given that HIQA reviewed high dose vaccines as part of a cost effectiveness health technology assessment in early 2025 and concluded that high dose vaccine strategies were clin…
1198. Deputy Ken O'Flynn asked the Minister for Health to list the countries where high dose vaccines have been commercially available since 2010, and if they are typically the preferentially recommended option over standard dose for adults aged 60 or 65 years and older in many of these countries; given that NIAC themselves also reviewed their own guidelines in mid-2025 without making any alterations, if she will exp…
1199. Deputy Ken O'Flynn asked the Minister for Health the reason the her Department did not request NIAC to update recommendations last year to facilitate the public good for flu season 2026/27, given that NIAC also reviewed their own guidelines in mid-2025 without making any alterations; if she will now seek to cancel the tender; the steps she will take to ensure that high dose vaccines are reviewed by NIAC immedia…
1200. Deputy Ken O'Flynn asked the Minister for Health to ensure the current tender process for season 2026/27 will go ahead; the reason she would not consider the creation of a pathfinder programme, as developed for the temporary usage of monoclonal antibody in RSV for the past two seasons (details supplied). [12698/26]
2315. Deputy Ken O'Flynn asked the Minister for Health the influenza vaccination uptake rates to date for the 2025–2026 season, broken down by age cohort and risk group; how these figures compare with the same period in each of the previous three years; and what policy measures her Department has taken to address any identified decline in uptake. [75078/25]
2352. Deputy Ken O'Flynn asked the Minister for Health to set out the current pathway by which a person in Ireland who suffers a serious adverse reaction following vaccination may obtain compensation, including whether any ex-gratia or statutory routes exists; the number of cases compensated by the State since 2000; the total amounts paid, itemised by year and vaccine, if available; and if she will make a statement o…
2353. Deputy Ken O'Flynn asked the Minister for Health the timeline for the establishment of a State vaccine injury compensation scheme; the target go-live date; the proposed administrator; whether the scheme will be statutory or administrative; whether it will be retrospective to vaccinations administered since 2020; and if she will make a statement on the matter. [45667/25]
2354. Deputy Ken O'Flynn asked the Minister for Health the proposed standard of proof for eligibility under any State vaccine injury compensation scheme; whether determinations will operate on the balance of probabilities; whether presumptive conditions will be listed on a “vaccine injury table” with defined time-to-onset criteria, as used in comparable international schemes; and if she will make a statement on the m…
2355. Deputy Ken O'Flynn asked the Minister for Health if she will publish draft heads of bill or scheme rules for public consultation before commencement of a State vaccine injury compensation scheme; the planned appeals mechanism; whether appeals will lie to an independent tribunal; the expected average decision time; and if she will make a statement on the matter. [45669/25]
2356. Deputy Ken O'Flynn asked the Minister for Health whether legal costs in any State vaccine injury compensation scheme will be borne by the scheme for unsuccessful as well as successful applicants subject to basic merit thresholds, in line with international comparators; the projected annual budget impact and contingency provision for the first five years; and if she will make a statement on the matter. [45670/25…
2357. Deputy Ken O'Flynn asked the Minister for Health to provide the number of suspected adverse reaction reports for vaccines received by HPRA in each year from 2019 to 2025, disaggregated by vaccine, seriousness, age band and outcome; and to confirm the number of these cases that proceeded to any form of compensation or settlement. [45671/25]
2358. Deputy Ken O'Flynn asked the Minister for Health whether any planned State vaccine injury compensation scheme will cover non-COVID vaccines in the National Immunisation Programme; how childhood, HPV, influenza, and adult booster vaccines will be treated; whether coverage will extend to off-schedule but HSE-administered vaccines; and if she will make a statement on the matter. [45672/25]
2359. Deputy Ken O'Flynn asked the Minister for Health whether a State vaccine injury compensation scheme will include a tax-free lump-sum model, periodic payments, or both; the proposed award calibration for death, severe disability, loss of earnings, care, medical costs, and rehabilitation; whether indexation will apply; and if she will make a statement on the matter. [45673/25]
2360. Deputy Ken O'Flynn asked the Minister for Health to publish an annual report on vaccine adverse events and compensation, integrating HPRA pharmacovigilance data with scheme outcomes; to include rates per million doses administered by vaccine and year; and to benchmark Ireland against the EU and the UK. [45674/25]
2455. Deputy Ken O'Flynn asked the Minister for Health to publish an annual report on vaccine adverse events and compensation, integrating HPRA pharmacovigilance data with scheme outcomes; to include rates per million doses administered by vaccine and year; and to benchmark Ireland against the EU and the UK. [46187/25]
2458. Deputy Ken O'Flynn asked the Minister for Health if the scheme will recognise injuries following mixed-brand or heterologous schedules where causation apportionment is complex; the approach to multi-dose temporal associations; if a proportional liability model will apply; and if she will make a statement on the matter. [46190/25]
2462. Deputy Ken O'Flynn asked the Minister for Health if adverse events following vaccination administered outside HSE settings but within the State, or administered abroad to Irish residents, will be eligible; the way in which domicile and jurisdiction will be assessed; and if she will make a statement on the matter. [46194/25]
2463. Deputy Ken O'Flynn asked the Minister for Health if deaths temporally associated with vaccination will be eligible where a coroner's verdict is inconclusive but medical evidence supports probability; the evidentiary threshold; the role of independent medical experts; and if she will make a statement on the matter. [46195/25]